Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients

Blood ◽  
2001 ◽  
Vol 97 (2) ◽  
pp. 388-392 ◽  
Author(s):  
P. Ljungman
Keyword(s):  
Stem Cell ◽  
Cytomegalovirus Infection ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Transplant Recipients

scholarly journals Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain

2015 ◽  
Vol 53 (8) ◽  
pp. 2741-2744 ◽  
Author(s):  
Carlos Solano ◽  
Rafael de la Cámara ◽  
Lourdes Vázquez ◽  
Javier López ◽  
Estela Giménez ◽  
...  
Keyword(s):  
Stem Cell ◽  
Cytomegalovirus Infection ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Transplant Recipients ◽  
Cmv Infection ◽  
Infection Management ◽  
Therapy Strategies ◽  
Cmv Disease

This study gathered information about current practices of cytomegalovirus (CMV) infection management in allogeneic stem cell transplant recipients at Spanish centers. A wide variety of preemptive antiviral therapy strategies for CMV infection guided by real-time PCR assays was found, yet the incidence of CMV disease was low (<3%).

Low-Dose Valganciclovir as Preemptive Therapy for Cytomegalovirus Infection Occurring in Allogeneic Stem Cell Transplant Recipients

2010 ◽  
Vol 123 (4) ◽  
pp. 230-234 ◽  
Author(s):  
Mariangela Palladino ◽  
Luca Laurenti ◽  
Patrizia Chiusolo ◽  
Paola Piccioni ◽  
Idanna Innocenti ◽  
...  
Keyword(s):  
Stem Cell ◽  
Cytomegalovirus Infection ◽  
Low Dose ◽  
Stem Cell Transplant ◽  
Preemptive Therapy ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document